Wednesday, August 3, 2016

Novartis pill gets U.S. breakthrough designation in breast cancer

ZURICH Aug 3 Novartis AG breast cancer
pill LEE011 has won breakthrough … for a form of advanced
breast cancer, the Swiss drugmaker said on … (HR+/HER2-) advanced or metastatic breast cancer.
The designation aims to expedite …

No comments:

Post a Comment